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Susan Lee Lindquist (1949–2016)—
pioneer in the study of cellular protein
folding and disease
Franz-Ulrich Hartl
The scientific community is deeply saddened
by the passing of Susan Lee Lindquist,
Professor of Biology at MIT and a Howard
Hughes Medical Institute Investigator, on
October 27 after a year-long battle with
cancer. Her nearly 40-year career was distin-
guished by groundbreaking research in cell
biology and genetics, and by an extraordi-
nary passion for nurturing and mentoring
the next generation of biologists.
An inspiring and courageous innovator,
Susan Lindquist has tackled and resolved a
remarkable variety of difficult problems,
ranging from delineating cellular responses
to stress, prion-based inheritance, and the
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role of protein misfolding in disease to
uncovering genetic variation in evolution.
Her interdisciplinary vision has empowered
her to devise entirely new experimental
approaches and create novel conceptual
frameworks in several fields.
Susan Lindquist’s work began with
pioneering studies of the heat-shock
response, a homeostatic mechanism to
protect cells from protein folding problems
during heat exposure and a variety of other
stresses. As a graduate student of Matthew
Meselson at Harvard in the 1970s, she
launched, on her own initiative, an investi-
gation of the heat-shock response, using it
as a model to understand eukaryotic gene
regulation. She discovered that the heat-
shock response, previously only known
from Drosophila salivary glands, also
occurred in tissue culture cells, demonstrat-
ing its generality and making it tractable to
molecular analysis. She then revealed that
the response was governed by a combina-
tion of translational and transcriptional
mechanisms. Thanks in large part to her
work—and complemented by seminal
contributions of Pelham, Lis, Morimoto, and
Wu—the heat-shock response provides
perhaps the most beautiful and complete
example of eukaryotic gene regulation docu-
mented to date.
After exploiting this system to produce
groundbreaking work on eukaryotic gene
expression, Susan studied the function of
the stress response and of two of its individ-
ual proteins, Hsp90 and Hsp104. These
investigations, carried out during her 23-year
tenure at the University of Chicago, led
to completely unexpected results. Using
yeast as a model, her laboratory found that
Hsp90 was essential for normal growth,
while Hsp104 was the single most critical
factor for surviving extreme stress. In collab-
oration with Keith Yamamoto, she estab-
lished in the early 1990s that Hsp90 was
required for the maturation of the steroid
hormone receptors and oncogenic tyrosine
kinases. Using a combination of genetic and
biochemical approaches, she demonstrated
that Hsp104 promotes survival after heat
stress by disaggregating damaged proteins
and restoring them to normal function. To do
so, Hsp104 couples its own conformational
changes, driven by highly coordinated
successive rounds of ATP hydrolysis, to work
on bound substrates. The functional analysis
of Hsp104 gave rise to another, most
remarkable discovery: In collaboration with
Chernoff and Liebman, Susan established
that Hsp104 regulates the propagation of a
mysterious cytoplasmically inherited
genetic factor known as [PSI+]. Taken
together with the fact that Hsp104 is a
protein remodeling factor, this finding
provided a strong genetic argument in
support of Reed Wickner’s proposal that
[PSI+] is a protein-based genetic element—
a prion. Susan established that the protein
suspected of being a prion, Sup35, under-
went a self-perpetuating change in state
that was inherited through the cytoplasmic
transmission of protein aggregates from
mother cells to their daughters. Remark-
ably, once the protein has switched states,
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from random coil to amyloid filament, it
can rapidly catalyze the conforma-
tional conversion of soluble protein. This
established the fundamental biochemical
mechanism for prion conversion that is
not only the basis of human prion disease
but is also of broad potential biological
significance. Indeed, collaborating with the
laboratory of Eric Kandel, Susan established
in 2003 a remarkable new concept in
learning and memory. They found that a
protein known as CPEB, which plays a key
role in the maintenance of synapses in
metazoan brains, has a prion-like ability to
sustain itself in an altered self-perpetuating
conformation.
The role of Hsp90 in the maturation of
steroid receptors and tryosine kinases
placed the protein in a unique position to
couple environmental contingency with
evolutionary change. In the mid-1990s,
Susan made the stunning discovery in
Drosophila that Hsp90 buffers naturally
occurring genetic variation. The presence of
Hsp90 allows flies to accumulate a multi-
tude of mutations by keeping them in a
silent state. Under stress, the effects of the
variation are exposed creating new traits,
and the variation can therefore be enriched
by selective breeding. Once the mutations
have been sufficiently enriched, the pheno-
types are retained, even when the environ-
ment has returned to normal. Subsequently,
the Lindquist laboratory extended this
novel concept to Arabidopsis, demonstrat-
ing that Hsp90’s capacity to buffer and
release genetic variation is conserved across
enormous evolutionary distances. They also
showed that drug resistance in pathogenic
fungi develops in an Hsp90-dependent
mechanism.
In 2001, Susan moved to the Whitehead
Institute in Cambridge, serving as its Director
until 2004. During more recent years, much
of her research focused on understanding the
role of molecular chaperones and stress
response pathways in neurodegenerative
diseases and in cancer. Using yeast as a
“living test tube”, they recapitulated the
protein folding transitions involved in the
pathogenic aggregation of alpha-synuclein in
Parkinson’s disease, huntingtin in Hunting-
ton’s chorea and PrP in prion disease, and
through ingenious genetic screens deci-
phered key cellular pathways that are
impaired by the aggregation process. Recon-
necting with her very early work on the
heat-shock response, she discovered that
heat-shock transcription factor, HSF1, also
drives a transcriptional program distinct from
heat shock to support the progression of
highly malignant human cancers. The
insights gained from these studies inform on
new therapeutic strategies for neurodegener-
ation and cancer. Indeed, not only was
Susan’s advice sought by major pharmaceuti-
cal companies, as a biomedical entrepreneur
she co-founded FoldRx Pharmaceuticals
and founded Yumanity Therapeutics and
REVOLUTIONMedicines.
It is impossible to imagine a more
fulfilled and productive scientific career than
that of Susan Lindquist. But Susan had
many other qualities that make losing her so
much harder. She was an outstanding
communicator and science advocate. Her
infectious enthusiasm for science always
helped to create an atmosphere of open and
friendly exchange at conferences. Furthering
excellence in science and providing support
for young scientists was of great importance
to her. She was highly regarded as a
passionate mentor and a role model for
women in science. She leaves a legacy of
students and postdocs who went on to
successful careers. Her views of our profes-
sion and of its significance for humanity are
wonderfully summarized in a statement she
made on the occasion of the 50th anniversary
of ASCB (http://www.molbiolcell.org/conte
nt/21/22/3804.long). I highly recommend
reading it, especially to the young.
Susan Lindquist received many presti-
gious awards and honors, including the
President’s National Medal of Science—the
highest scientific honor bestowed by
the United States—as well as the Dickson
Prize in Medicine, the Otto-Warburg Medal,
the FASEB Excellence in Science Award, the
Max Delbru¨ck Medal, the E.B. Wilson
Medal, a Vallee Visiting Professorship, the
Vanderbilt Prize for Women’s Excellence in
Science and Mentorship, and the Albany
Prize. She was a member of the National
Academy of Sciences, the American
Academy of Arts and Sciences, and the
British Royal Society.
In Susan Lindquist we are losing not only
a towering figure of basic biomedical
research, but also a wonderful human being.
I will never forget her warmhearted friend-
ship, her youthful enthusiasm and her great
sense of humor. Susan is survived by her
husband, Edward Buckbee, and her two
daughters, Alana Buckbee and Nora Buckbee.
She will live on in our memories and through
her extraordinary achievements.
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